- Advertisement -spot_img
Sunday, May 22, 2022

Padres sign Robinson Canoe, plan to use him off the bench

ATLANTA ( Associated Press) — The San Diego Padres have signed veteran second baseman Robinson Canoe to a major league contract and plans to use him as a left-hander off the bench.

Canoe was not in Friday’s lineup against the Atlanta Braves. Acting manager Ryan Christensen said he could get some occasional starts on second and designated hitters.

The New York Mets, who released Canoe on Sunday, have about $45 million left on their original contract signed with Seattle. He will earn a pro-rata share of a minimum of $700,000.

Canoe, 39, was named for the assignment on May 2 for the NL East-leading Mets after hitting .195 with a home run and three RBIs in 43 plate appearances. He was serving a second suspension for performance-enhancing drugs last season.

Canoe has a career batting average of .302 with 335 home runs, 1,305 RBIs and .842 OPS in 17 seasons. He has 2,632 hits, including 571 in doubles. Canoe is owed about $45 million to the Mets, with the remaining $240 million to the 10-year contract he signed with Seattle. He has lost more than $35 million due to two drug suspensions.

With the fourth-highest career batting average among all active major league players, Cano is behind Miguel Cabrera (.310), Jose Altuve (.307) and Mike Trout (.305). He ranks third among active players in hits, RBI, total bases, extra-base hits and runs scored. Canoe has 316 homers as second baseman, second only to Jeff Kent’s 351.

The Padres selected pitcher Dinelson Lamet for Triple-A El Paso in the same move.


More Associated Press MLB: https://apnews.com/hub/mlb and https://twitter.com/AP_Sports

World Nation News Deskhttps://www.worldnationnews.com
World Nation News is a digital news portal website. Which provides important and latest breaking news updates to our audience in an effective and efficient ways, like world’s top stories, entertainment, sports, technology and much more news.
Latest news
Related news
- Advertisement -


Please enter your comment!
Please enter your name here